API
< Back to all clusters
[HEALTH] · China · 7 sources

started · updated

Shanghai child’s death prompts probe of experimental gene‑editing therapy

A six‑year‑old Chinese girl, identified by the pseudonym Mei, died a week after receiving an experimental CRISPR‑derived base‑editing therapy in March 2025 at Xinhua Hospital in Shanghai. The treatment, led by neuroscientist Zilong Qiu, involved injecting millions of viral vectors into the cerebrospinal fluid to target a brain mutation causing Snijders‑Blok‑Campeau syndrome. Mei’s parents funded the procedure at a cost of about $860,000.

The death was not disclosed in the trial’s later scientific publication and was uncovered by investigations from the journal Science and Retraction Watch. Following the revelation, Shanghai Jiao Tong University opened a formal investigation and created a special working group, while the municipal health commission intervened and the hospital received a fine from local health authorities. Investigators cite a severe immune reaction or thrombotic microvascular disease as the likely cause of death.

Entities

CRISPR base editing · Chinese health authorities · Mei (6‑year‑old girl) · Mei (pseudonym) · Science (journal) · Shanghai Health Commission · Shanghai Jiao Tong University · Snijders-Blok-Campeau syndrome · Snijders‑Blok‑Campeau syndrome · Xinhua Hospital · Xinhua Hospital (Shanghai) · Xinhua Hospital (Shanghai)

Claims

What the coverage asserts, and how many sources carry each claim.